Announce Date | 05/09/2024 |
EPS Normalized Actual | $-0.26 (Miss by $-0.02) |
EPS GAAP Actual | $-0.26 (Miss by $-0.02) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.34259 |
EPS GAAP Estimate | $1.34259 |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 4.02 | 1.15 | 4.02 | 4.02 | 1 |
Dec 2027 | 2.42 | 1.9 | 2.42 | 2.42 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.8 | 0.02 | 0B | NAN% | 0M |
FQ4 2021 (Dec 2021) | -0.76 | 29.07 | 0B | NAN% | -0.06M |
FQ3 2021 (Sep 2021) | -0.71 | -0.71 | 0B | NAN% | 0M |
FQ2 2021 (Jun 2021) | -1.53 | -1.53 | 0B | NAN% | 0M |
FQ1 2021 (Mar 2021) | -1.3 | -1.3 | 0B | NAN% | 0M |
FQ4 2020 (Dec 2020) | -0.77041 | -0.77041 | 0B | NAN% | 0M |
FQ3 2020 (Sep 2020) | -1.14 | -1.14 | 0B | NAN% | 0M |
FQ2 2020 (Jun 2020) | -1.68 | -1.68 | 0B | NAN% | 0M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | -0.14 | -- | -0.14 | -0.14 | 1 |
FQ2 2025 (Jun 2025) | -0.36 | -- | -0.36 | -0.36 | 1 |
FQ1 2025 (Mar 2025) | -0.3 | -- | -0.3 | -0.3 | 1 |
FQ4 2024 (Dec 2024) | -0.34 | -- | -0.34 | -0.34 | 0 |
FQ3 2024 (Sep 2024) | 1.54141 | -- | 2.00153 | 1.24233 | 3 |
FQ2 2024 (Jun 2024) | 1.34259 | -- | 1.74336 | 1.08209 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | 0B | -- | 0B | 0B | 0 |
FQ2 2025 (Jun 2025) | 0B | -- | 0B | 0B | 0 |
FQ1 2025 (Mar 2025) | 0B | -- | 0B | 0B | 0 |
FQ4 2024 (Dec 2024) | 0B | -- | 0B | 0B | 0 |
FQ3 2024 (Sep 2024) | 0B | -- | 0B | 0B | -46 |
FQ2 2024 (Jun 2024) | 0B | -- | 0B | 0B | -46 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
1
Revenue # of in-lines
7
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.82 | -0.8 | 0.02 | -2.5% |
FQ4 2021 (Dec 2021) | -29.83 | -0.76 | 29.07 | -3825% |
FQ3 2021 (Sep 2021) | -0.71 | -0.71 | 100% | |
FQ2 2021 (Jun 2021) | -1.53 | -1.53 | 100% | |
FQ1 2021 (Mar 2021) | -1.3 | -1.3 | 100% | |
FQ4 2020 (Dec 2020) | -0.77041 | -0.77041 | 100% | |
FQ3 2020 (Sep 2020) | -1.14 | -1.14 | 100% | |
FQ2 2020 (Jun 2020) | -1.68 | -1.68 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |
FQ4 2021 (Dec 2021) | $0B | $0B | $-0.06M | -INF% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |
FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
FQ3 2020 (Sep 2020) | $0B | $0B | $0M | NAN% |
FQ2 2020 (Jun 2020) | $0B | $0B | $0M | NAN% |